This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Tan, Y.-C. Articles by Rennert, H. Search for Related Content PubMed PubMed Citation Articles by Tan, Y.-C. Articles by Rennert, H.

Common 8q24 Sequence Variations Are Associated with Asian Indian Advanced Prostate Cancer Risk

¹ Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York; ² Center for Clinical Epidemiology & Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania; and ³ Departments of Medical Genetics and Urology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India

Requests for reprints: Hanna Rennert, Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, 1300 York Avenue, F701, New York, NY 10065. Phone: 212-746-6412; Fax: 212-746-4483. E-mail: har2006{at}med.cornell.edu

Three sequence variations (rs1447295, rs16901979, and rs6983267) on 8q24 were recently shown to independently affect prostate cancer risk. Asian Indians have a low prostate cancer risk; however, in the absence of screening practices for the disease, most are diagnosed with metastatic prostate cancer. We evaluated the association of these single nucleotide polymorphisms (SNP) with advanced prostate cancer in 153 prostate cancer cases and 227 age-matched controls (northern India). Overall, there was a positive association between carriers of the allele A of rs1447295 and prostate cancer risk [odds ratio (OR), 1.60; 95% confidence interval (95% CI), 1.01-2.52] but no significant association with carriers of alleles A of rs16901979 and allele G of rs6983267. However, significant associations were observed for both SNPs in men with high Gleason scores (7) and metastasis. Adjusting for age, the ORs were 1.77 (95% CI, 1.05-2.97) for carriers of rs1447295 A and 1.85 (95% CI, 1.04-3.28) for carriers of the rs16901979 A allele. We also observed significant joint effects among these loci associated with prostate cancer risk and severity, suggestive of additive effects of the independent SNPs. The ORs for the combined effects of rs1447295 A with rs16901979 A or rs6983267 G were 2.61 (95% CI, 1.11-6.12) and 1.84 (95% CI, 1.12-3.06), respectively. There was no joint effect between SNPs rs16901979 A and rs6983267 G. These results confirm the significance of these SNPs in prostate cancer etiology in a previously unstudied population who do not undergo prostate cancer screening and are diagnosed with severe disease. (Cancer Epidemiol Biomarkers Prev 2008;17(9):2431–5)